ROCKWELL MEDICAL, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 USD | -2.95% |
|
-8.02% | -21.16% |
| Apr. 04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
| Mar. 25 | HC Wainwright Cuts Price Target on Rockwell Medical to $9 From $11, Keeps Buy Rating | MT |
Presentation Operator MessageOperator (Operator)Good morning, and welcome to Rockwell Medical'...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patientâs bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.525
USD
Average target price
7
USD
Spread / Average Target
+359.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.16% | 44.74M | |
| +27.63% | 676B | |
| +24.27% | 559B | |
| -8.29% | 356B | |
| +15.11% | 320B | |
| +5.30% | 286B | |
| +2.62% | 213B | |
| +0.15% | 207B | |
| -9.41% | 199B | |
| -7.95% | 142B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Transcript : Rockwell Medical, Inc., Q2 2022 Earnings Call, Aug 15, 2022
